We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Vinci SA (PK) | USOTC:VCISY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.35 | 1.35% | 26.35 | 26.26 | 26.62 | 26.55 | 26.30 | 26.35 | 211,945 | 21:01:36 |
By Kathryn Hardison
International stocks trading in New York closed mostly higher on Monday.
The S&P/BNY Mellon index of American depositary receipts rose 0.3% to 129.13. The European index increased 0.6% to 126.62, the Asian index rose 0.4% to 142.78, the Latin American index fell 3.1% to 188.94 and the emerging markets index dropped 0.4% to 245.72.
GSK PLC and Erste Group Bank AG were among the companies with ADRs that traded actively.
ADRs of GSK fell 3.2% after the drug company reported a setback in advanced trials of a treatment for bone-marrow cancer. The company said that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn't meet its primary endpoint of progression-free survival. The company said additional trials will continue and further data from the studies are anticipated in the first half of 2023.
ADRs of Erste Group Bank rose 2.1% after the Austrian bank said it has signed a contract to potentially acquire the active loan portfolio of Russian bank Sberbank's Czech arm in liquidation.
ADRs of Vinci SA fell 1.6% after the French infrastructure company said its construction subsidiary has been summoned to court over charges relating to a complaint about working conditions at its sites in Qatar.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
November 07, 2022 18:10 ET (23:10 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Vinci (PK) Chart |
1 Month Vinci (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions